Table 3.
HIV-Plasmodium vivax co-infection case reports
| Author, year | Sex/age | Viral load (copies/mL) | CD4 + cell count (cells/μL) | Primoinfection/semiquantitative parasitemia (+) | Concomitant conditions/co-morbidities | AIDS defining illness | ARV treatment/adherence | Severe malaria (WHO criteria) |
|---|---|---|---|---|---|---|---|---|
| Katongole-Mbidde, 1988 [36] | F, 37 | NDa | NDa | ND/ND |
PNM (Pneumocystis jirovecii) |
Yes | ND | No |
| McIver, 2010 [37] | M, 57 | 0 | 500 | ND/+ + + | PNM | Yes | 3TC + AZT + ATV/yes | No |
| Tano, 2014 [84] | M, 50 | 2352 | 115 | No/patient was diagnosed by IFI | ND | No | ND/No | Anemia (5.6 g/dL) |
| Ranaweera, 2018 [38] | M, 36 | ND | ND | No/+ + + b | TB/PNM (Pneumocystis jirovecii) | Yes | ND | Hyperbilirubinemia (total bilirubin = 5.03), Shock (Systolic BP < 80 mmHg) |
| Montenegro-Idrogo, 2019 [39] | F, 35 | 105,000b | 350b | Yes/+ + | ND | No | No | Impaired consciousness (Glascow coma score 6/15) |
| M, 43 | ND | ND | Yes/+ b | ND | No | No | No |
M male, F female, BP blood pressure, TB tuberculosis, PNM pneumonia, 3Tc lamivudine, IFI indirect immunofluorescence, AZT zidovudine/azidothymidine, ATV atazanavir, TDF tenofovir, ND not defined
aRDT positive at hospital admission
bAt hospital admission